In a Law360 article, health care partner Margaux Hall, who leads the firm’s drug pricing and price reporting group, noted that President Trump’s recent executive orders—rescinding President Biden’s drug pricing CMMI directives—do not alter the Medicare negotiation program under the Inflation Reduction Act, as that negotiation program “has its own legal authority under federal law.”
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.